226 related articles for article (PubMed ID: 15505426)
1. Suppression of apoptosis in perfusion culture of Myeloma NS0 cells enhances cell growth but reduces antibody productivity.
Tey BT; Al-Rubeai M
Apoptosis; 2004 Nov; 9(6):843-52. PubMed ID: 15505426
[TBL] [Abstract][Full Text] [Related]
2. Effect of Bcl-2 overexpression on cell cycle and antibody productivity in chemostat cultures of myeloma NS0 cells.
Tey BT; Al-Rubeai M
J Biosci Bioeng; 2005 Sep; 100(3):303-10. PubMed ID: 16243281
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cell cycle for enhancement of antibody productivity in perfusion culture of NS0 cells.
Ibarra N; Watanabe S; Bi JX; Shuttleworth J; Al-Rubeai M
Biotechnol Prog; 2003; 19(1):224-8. PubMed ID: 12573029
[TBL] [Abstract][Full Text] [Related]
4. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
[TBL] [Abstract][Full Text] [Related]
5. Improvement of a mammalian cell culture process by adaptive, model-based dialysis fed-batch cultivation and suppression of apoptosis.
Frahm B; Lane P; Märkl H; Pörtner R
Bioprocess Biosyst Eng; 2003 Nov; 26(1):1-10. PubMed ID: 14505167
[TBL] [Abstract][Full Text] [Related]
6. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
Spens E; Häggström L
Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
[TBL] [Abstract][Full Text] [Related]
7. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
[TBL] [Abstract][Full Text] [Related]
8. Enhanced growth in NS0 cells expressing aminoglycoside phosphotransferase is associated with changes in metabolism, productivity, and apoptosis.
Veraitch FS; Al-Rubeai M
Biotechnol Bioeng; 2005 Dec; 92(5):589-99. PubMed ID: 16267848
[TBL] [Abstract][Full Text] [Related]
9. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
Seifert DB; Phillips JA
Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
[TBL] [Abstract][Full Text] [Related]
10. High-level production of a monoclonal antibody in murine myeloma cells by perfusion culture using a gravity settler.
Choo CY; Tian Y; Kim WS; Blatter E; Conary J; Brady CP
Biotechnol Prog; 2007; 23(1):225-31. PubMed ID: 17269692
[TBL] [Abstract][Full Text] [Related]
11. Effect of feed and bleed rate on hybridoma cells in an acoustic perfusion bioreactor: part I. Cell density, viability, and cell-cycle distribution.
Dalm MC; Cuijten SM; van Grunsven WM; Tramper J; Martens DE
Biotechnol Bioeng; 2004 Dec; 88(5):547-57. PubMed ID: 15459904
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome and proteome analysis of antibody-producing mouse myeloma NS0 cells cultivated at different cell densities in perfusion culture.
Krampe B; Swiderek H; Al-Rubeai M
Biotechnol Appl Biochem; 2008 Jul; 50(Pt 3):133-41. PubMed ID: 18302537
[TBL] [Abstract][Full Text] [Related]
13. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
Dong H; Tang YJ; Ohashi R; Hamel JF
Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
[TBL] [Abstract][Full Text] [Related]
14. Glycosylation of an immunoglobulin produced from a murine hybridoma cell line: the effect of culture mode and the anti-apoptotic gene, bcl-2.
Majid FA; Butler M; Al-Rubeai M
Biotechnol Bioeng; 2007 May; 97(1):156-69. PubMed ID: 17013932
[TBL] [Abstract][Full Text] [Related]
15. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.
Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA
Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534
[TBL] [Abstract][Full Text] [Related]
16. A comparison of intensive cell culture bioreactors operating with hybridomas modified for inhibited apoptotic response.
Bierau H; Perani A; al-Rubeai M; Emery AN
J Biotechnol; 1998 Jul; 62(3):195-207. PubMed ID: 9729803
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures.
Tey BT; Singh RP; Piredda L; Piacentini M; Al-Rubeai M
J Biotechnol; 2000 Apr; 79(2):147-59. PubMed ID: 10812183
[TBL] [Abstract][Full Text] [Related]
18. Bcl-x(L) mediates increased production of humanized monoclonal antibodies in Chinese hamster ovary cells.
Chiang GG; Sisk WP
Biotechnol Bioeng; 2005 Sep; 91(7):779-92. PubMed ID: 15986489
[TBL] [Abstract][Full Text] [Related]
19. Inducible expression of Bcl-XL restricts apoptosis resistance to the antibody secretion phase in hybridoma cultures.
Jung D; Côté S; Drouin M; Simard C; Lemieux R
Biotechnol Bioeng; 2002 Jul; 79(2):180-7. PubMed ID: 12115434
[TBL] [Abstract][Full Text] [Related]
20. Continuous production of monoclonal antibody in a packed-bed bioreactor.
Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
